Investors 1
| Date | Name | Website |
| - | Lake Bleu ... | lakebleu-c... |
Mentions in press and media 1
| Date | Title | Description |
| 12.09.2025 | The New Drug Application for KN026 (Anbenitamab Injection) Has Been Accepted by the National Medical Products Administration | SUZHOU, China, Sept. 12, 2025 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) announced that the New Drug Application (NDA) for anbenitamab injection (KN026), independently developed by the Company and co-developed with JMT-Bio Tech... |